Acting FDA chief vows to shield rare-disease talks from politics
TL;DR
The acting FDA Commissioner pledged to prevent political interference at a meeting with 15 rare-disease nonprofit groups, signaling a commitment to keeping discussions on drug development and oversight free from political pressure.
- Acting FDA commissioner pledges to prevent political interference in rare disease meeting Endpoints News
- Acting US FDA chief meets with rare disease groups to mend fences Reuters
- FDA's Acting Chief Seeks to Rebuild Ties with Rare Disease Sector Devdiscourse
- Opinion: The next FDA commissioner must be a champion for gene therapies BioSpace
- FDA Acting Head to Meet Closed-Door With Rare Disease Groups (1) Bloomberg Law News
Want the full story? Read the original reporting
Read on Endpoints News